Cargando…
A Four-MicroRNA Panel in Serum as a Potential Biomarker for Screening Renal Cell Carcinoma
Background: Renal cell carcinoma (RCC) has been a major health problem and is one of the most malignant tumors around the world. Serum microRNA (miRNA) profiles previously have been reported as non-invasive biomarkers in cancer screening. The aim of this study was to explore serum miRNAs as potentia...
Autores principales: | Li, Rongkang, Lu, Chong, Li, Xinji, Chen, Xuan, Huang, Guocheng, Wen, Zhenyu, Li, Hang, Tao, Lingzhi, Hu, Yimin, Zhao, Zhengping, Chen, Zebo, Lai, Yongqing |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9355293/ https://www.ncbi.nlm.nih.gov/pubmed/35938021 http://dx.doi.org/10.3389/fgene.2022.897827 |
Ejemplares similares
-
A four-microRNA panel in serum may serve as potential biomarker for renal cell carcinoma diagnosis
por: Li, Rongkang, et al.
Publicado: (2023) -
A panel of three serum microRNA can be used as potential diagnostic biomarkers for nasopharyngeal carcinoma
por: Li, Rongkang, et al.
Publicado: (2022) -
Use of a Four-miRNA Panel as a Biomarker for the Diagnosis of Stomach Adenocarcinoma
por: Chen, Xuan, et al.
Publicado: (2020) -
Identification of a three-miRNA panel in serum for bladder cancer diagnosis by a diagnostic test
por: Li, Rongkang, et al.
Publicado: (2022) -
Evaluation of Serum miR-17-92 Cluster as Noninvasive Biomarkers for Bladder Cancer Diagnosis
por: Wang, Jingyao, et al.
Publicado: (2021)